Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Self-medication of heartburn and acid regurgitation, which is effective for up to 24 hours and allows for sustained symptom relief
Subscribe to our email newsletter
Bayer Vital is going to launch the OTC Proton Pump Inhibitor (PPI), omeprazole in Germany under the Antra brand, beginning in August.
With Antra, patients would have a new option for self-medication of heartburn and acid regurgitation with one tablet, which is effective for up to 24 hours and allows for sustained symptom relief.
The company said that it has received an OTC license for omeprazole from AstraZeneca for the marketing of omeprazole. The licensing agreement with AstraZeneca also includes options for Bayer to market omeprazole in other countries, following the first launch in Germany.
The company has submitted an application for the release of omeprazole from prescription-only status at a maximum daily dose of 20mg, with a maximum pack size of 14 tablets (280mg).